V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20036386 | 20085993 | 1.7 | 75.4 | Palliative (P) | 2018-11-24 | 2018-12-16 | CAPECITABINE + CARBOPLATIN + Trastuzumab | N | N | FOXTROT TRIAL | 100203970 |
| 20036405 | 20085994 | 0 | 158 | Adjuvant (A) | null | 2017-03-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | BENDAMUSTINE + RITUXIMAB | 100209762 |
| 20036420 | 20085995 | 1.65 | 95.5 | 03 | 2018-07-27 | 2018-08-23 | SCOPE 2 TRIAL | 02 | N | IBRUTINIB | 100643207 |
| 20036521 | 20085996 | 1.41 | 81.05 | Adjuvant (A) | 2019-07-21 | 2019-07-25 | NAB PACLITAXEL | 02 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100083221 |
| 20036582 | 20085997 | 1.81 | 38.7 | 03 | 2019-02-20 | 2019-03-03 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | DABRAFENIB + TRAMETINIB | 101400316 |
| 20036647 | 20085998 | null | 52.1 | Curative (C) | 2019-06-24 | 2019-06-28 | EOF | null | N | STS NON-RHABDO EPSSG 2005 VDCY | 101037606 |
| 20036706 | 20086000 | 1.61 | 0 | Palliative (P) | 2018-08-11 | 2018-08-11 | Capecitabine + Carboplatin + RT | N | N | CHOP R | 100081347 |
| 20036720 | 20086001 | 1.55 | 84 | 03 | 2017-02-26 | 2017-03-08 | Abiraterone | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101429852 |
| 20036754 | 20086002 | 1.71 | 86.8 | null | 2017-06-19 | 2017-06-21 | Rituximab (INTRAVENOUS Maintenance) | 2 | N | VENETOCLAX | 100808620 |
| 20036766 | 20086003 | 1.59 | 91.15 | Palliative (P) | 2016-11-08 | 2016-11-12 | null | null | N | CAPITAL TRIAL | 100470711 |
| 20036820 | 20086005 | 1.74 | 46.5 | 03 | null | 2015-11-19 | ACELARATE Trial | 1 | null | NEO-AEGIS TRIAL | 100009880 |
| 20036848 | 20086006 | 0 | 69.8 | 03 | 2020-01-10 | 2020-01-12 | ARISTOTLE TRIAL | 02 | N | CAP + RT | 100264395 |
| 20036869 | 20086007 | 0 | 0 | Palliative (P) | 2018-10-01 | 2018-10-15 | PHITT B or C Cisplatin | N | N | CETUXIMAB + ENCORAFENIB | 101011266 |
| 20036950 | 20086008 | 1.72 | 79.8 | Palliative (P) | 2019-02-23 | 2019-02-27 | Cape+Cetuximab+Oxalip (2 wk) Load | 02 | N | CHOP R | 101067429 |
| 20036951 | 20086009 | 1.5 | 103.1 | 03 | 2019-10-19 | 2019-10-27 | Everolimus 10mg | 02 | null | CARBOPLATIN + PEMETREXED | 100971196 |
| 20036956 | 20086010 | 1.64 | 56.8 | Palliative (P) | 2018-11-24 | 2018-12-15 | Panitumumab | 02 | N | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101432856 |
| 20036971 | 20086011 | 1.7 | 63 | 03 | null | 2015-03-31 | Carboplatin + Vinorelbine IV | 2 | N | CISPLATIN + TRASTUZUMAB | 101383914 |
| 20036995 | 20086012 | 1.71 | 116 | null | null | 2017-11-10 | OXALIPLATIN | 01 | N | CHLORAMBUCIL + RITUXIMAB | 100722766 |
| 20037006 | 20086013 | 1.64 | 95.35 | Palliative (P) | 2016-02-21 | 2016-02-21 | ARISTOTLE TRIAL | 02 | N | CARBOPLATIN + FLUOROURACIL | 101141852 |
| 20037011 | 20086014 | 1.67 | 70 | Palliative (P) | 2019-12-28 | 2020-01-04 | OXALIPLATIN | 02 | N | HEP SIOPEL 6 CISPLATIN | 100257496 |
| 20037082 | 20086016 | 1.68 | 79.2 | 03 | 2014-05-24 | 2014-05-31 | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100716856 |
| 20037094 | 20086017 | 1.56 | 44.1 | Palliative (P) | null | 2020-05-12 | PEMBROLIZUMAB | null | N | DOXORUBICIN | 100447458 |
| 20037123 | 20086019 | 1.55 | 104 | null | 2018-09-18 | 2018-09-18 | ESHAP R | 02 | N | IRINOTECAN | 100077772 |
| 20037127 | 20086020 | null | 16.5 | null | 2019-08-05 | 2019-09-06 | Trabectedin | 02 | N | GEMCITABINE + PACLITAXEL | 101718859 |
| 20037140 | 20086021 | 1.77 | 92.6 | Palliative (P) | 2019-07-07 | 2019-07-13 | ECarboX | 02 | N | CISPLATIN + DOCETAXEL | 101424604 |
| 20037179 | 20086022 | 1.65 | 63.7 | Palliative (P) | 2019-05-22 | 2019-05-29 | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 01 | Y | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100263655 |
| 20037204 | 20086023 | 1.77 | 68 | Palliative (P) | 2020-02-07 | 2020-02-14 | IBRUTINIB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100487390 |
| 20037250 | 20086024 | 1.55 | 111 | 03 | 2018-07-16 | 2018-07-17 | Irinotecan | N | N | CETUXIMAB + RT | 100343669 |
| 20037370 | 20086027 | 1.86 | null | 03 | 2018-01-21 | 2018-01-24 | Cisplatin + Fluorouracil + RT 5day | 02 | N | ACELARATE TRIAL | 100484002 |
| 20037375 | 20086028 | 1.63 | 94 | 03 | 2018-03-15 | 2018-03-15 | OXALIPLATIN | 02 | N | HYDROXYCARBAMIDE | 100308197 |
| 20037382 | 20086029 | 1.75 | 73.6 | 03 | 2018-06-22 | 2018-06-24 | Rituximab | 01 | N | ARISTOTLE TRIAL | 101264006 |
| 20037409 | 20086030 | 1.65 | 71.5 | Neo-adjuvant (N) | 2018-01-21 | 2018-01-27 | CISPLATIN + VINORELBINE | 01 | N | ACTICCA-1 TRIAL | 101670094 |
| 20037420 | 20086031 | 1.88 | 76.6 | null | 2019-07-17 | 2019-07-21 | Azacitidine | 02 | Y | SCOPE2 TRIAL | 101868544 |
| 20037463 | 20086032 | 1.78 | 83.6 | Palliative (P) | 2019-08-20 | 2019-09-16 | Panitumumab | 02 | Y | CISPLATIN + FLUOROURACIL + RT | 100843603 |
| 20037514 | 20086033 | 1.75 | 68.2 | Palliative (P) | 2019-07-07 | 2019-07-29 | PHITT C SIOPEL-3HR | 02 | N | ACTICCA-1 TRIAL | 101286616 |
| 20037516 | 20086034 | 1.63 | null | 03 | 2018-01-27 | 2018-02-21 | ESPAC-4 TRIAL | N | N | HYDROXYCARBAMIDE | 101050356 |
| 20037556 | 20086035 | 1.69 | 76 | Palliative (P) | 2016-10-06 | 2016-10-18 | ECarboX | Y | N | REGORAFENIB | 101376607 |
| 20037561 | 20086036 | null | null | Curative (C) | 2019-01-11 | 2019-02-07 | ARISTOTLE TRIAL | null | N | DOCETAXEL | 100960708 |
| 20037663 | 20086039 | 1.67 | 72 | Palliative (P) | 2018-01-26 | 2018-03-06 | SCOPE 2 TRIAL | 02 | Y | ESPAC TRIAL | 101470428 |
| 20037671 | 20086040 | 1.69 | 81.6 | Neo-adjuvant (N) | 2010-05-22 | 2019-04-16 | LENALIDOMIDE | 02 | N | CHLORAMBUCIL | 100974552 |
| 20037681 | 20086041 | 1.6 | 72.9 | 03 | 2019-05-06 | 2019-05-06 | Everolimus 10mg | 02 | N | STS NON-RHABDO EPSSG 2005 VDCY | 101675088 |
| 20037694 | 20086042 | 1.7 | 47.5 | 03 | 2018-01-25 | 2018-02-14 | MITOMYCIN | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100551557 |
| 20037705 | 20086043 | 1.5 | 96.85 | 03 | 2016-04-27 | 2016-04-28 | IVA | 02 | N | EVEROLIMUS | 101312005 |
| 20037778 | 20086045 | 1.8 | 68.5 | Adjuvant (A) | 2018-03-06 | 2018-03-06 | FOXFIRE TRIAL | 02 | N | PANITUMUMAB | 101449112 |
| 20037791 | 20086046 | 1.8 | 92.1 | Palliative (P) | 2019-03-10 | 2019-03-31 | Bortezomib + MELPHALAN | Y | N | DOCETAXEL | 101535718 |
| 20037809 | 20086047 | 1.63 | 86.8 | null | 2016-09-20 | 2016-10-18 | Palbociclib | 2 | N | ARISTOTLE TRIAL | 101508435 |
| 20037819 | 20086048 | null | 71 | Palliative (P) | 2017-05-17 | 2017-05-27 | GEMCARBO | 02 | null | CARBOPLATIN + PEMETREXED | 101336440 |
| 20037826 | 20086049 | 1.66 | 91 | 03 | 2020-06-13 | 2020-06-16 | Capecitabine + Streptozocin | 02 | N | RITUXIMAB | 101220416 |
| 20037851 | 20086050 | 1.82 | 70 | 03 | 2020-11-16 | 2020-12-07 | Cape +Cetuximab +Oxalip (3 wk) Load | 02 | N | RITUXIMAB | 101030199 |
| 20037884 | 20086051 | 1.82 | 68.8 | null | 2019-01-06 | 2019-01-17 | PEMBROLIZUMAB | 02 | N | ECARBOX | 100246731 |